Seeking Alpha

Northwest Bio closes convertible debt offering

  • Northwest Biotherapeutics (NWBO -2.1%) closes a $17.5M convertible note paying 5% interest for a term of three years. The notes are convertible into common stock at $7.50 per share. Investors also have three-month option to buy an additional 30% of the notes.
  • Proceeds will be used to fund increased manufacturing capacity and ongoing clinical trials.
  • NWBO shares closed today at $5.98.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs